These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9053504)

  • 1. Phase I trial of tirapazamine in combination with cisplatin in a single dose every 3 weeks in patients with solid tumors.
    Johnson CA; Kilpatrick D; von Roemeling R; Langer C; Graham MA; Greenslade D; Kennedy G; Keenan E; O'Dwyer PJ
    J Clin Oncol; 1997 Feb; 15(2):773-80. PubMed ID: 9053504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tirapazamine with cisplatin in patients with advanced non-small-cell lung cancer: a phase II study.
    Treat J; Johnson E; Langer C; Belani C; Haynes B; Greenberg R; Rodriquez R; Drobins P; Miller W; Meehan L; McKeon A; Devin J; von Roemeling R; Viallet J
    J Clin Oncol; 1998 Nov; 16(11):3524-7. PubMed ID: 9817270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of the hypoxic cell cytotoxic agent tirapazamine and its major bioreductive metabolites in mice and humans: retrospective analysis of a pharmacokinetically guided dose-escalation strategy in a phase I trial.
    Graham MA; Senan S; Robin H; Eckhardt N; Lendrem D; Hincks J; Greenslade D; Rampling R; Kaye SB; von Roemeling R; Workman P
    Cancer Chemother Pharmacol; 1997; 40(1):1-10. PubMed ID: 9137522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I and pharmacokinetic study of tirapazamine (SR 4233) administered every three weeks.
    Senan S; Rampling R; Graham MA; Wilson P; Robin H; Eckardt N; Lawson N; McDonald A; von Roemeling R; Workman P; Kaye SB
    Clin Cancer Res; 1997 Jan; 3(1):31-8. PubMed ID: 9815534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tirapazamine plus cisplatin versus cisplatin in advanced non-small-cell lung cancer: A report of the international CATAPULT I study group. Cisplatin and Tirapazamine in Subjects with Advanced Previously Untreated Non-Small-Cell Lung Tumors.
    von Pawel J; von Roemeling R; Gatzemeier U; Boyer M; Elisson LO; Clark P; Talbot D; Rey A; Butler TW; Hirsh V; Olver I; Bergman B; Ayoub J; Richardson G; Dunlop D; Arcenas A; Vescio R; Viallet J; Treat J
    J Clin Oncol; 2000 Mar; 18(6):1351-9. PubMed ID: 10715308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I study of tirapazamine and cisplatin in patients with recurrent cervical cancer.
    Aghajanian C; Brown C; O'flaherty C; Fleischauer A; Curtin J; Roemeling R; Spriggs DR
    Gynecol Oncol; 1997 Nov; 67(2):127-30. PubMed ID: 9367694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of the combination of the novel bioreductive agent, tirapazamine, with cisplatin in patients with advanced non-small-cell lung cancer.
    Miller VA; Ng KK; Grant SC; Kindler H; Pizzo B; Heelan RT; von Roemeling R; Kris MG
    Ann Oncol; 1997 Dec; 8(12):1269-71. PubMed ID: 9496394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I trial of docetaxel and cisplatin in previously untreated patients with advanced non-small-cell lung cancer.
    Millward MJ; Zalcberg J; Bishop JF; Webster LK; Zimet A; Rischin D; Toner GC; Laird J; Cosolo W; Urch M; Bruno R; Loret C; James R; Blanc C
    J Clin Oncol; 1997 Feb; 15(2):750-8. PubMed ID: 9053501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
    Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I trial of concurrent tirapazamine, cisplatin, and radiotherapy in patients with advanced head and neck cancer.
    Rischin D; Peters L; Hicks R; Hughes P; Fisher R; Hart R; Sexton M; D'Costa I; von Roemeling R
    J Clin Oncol; 2001 Jan; 19(2):535-42. PubMed ID: 11208848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Phase I and pharmacokinetic study of temozolomide and cisplatin in patients with advanced solid malignancies.
    Britten CD; Rowinsky EK; Baker SD; Agarwala SS; Eckardt JR; Barrington R; Diab SG; Hammond LA; Johnson T; Villalona-Calero M; Fraass U; Statkevich P; Von Hoff DD; Eckhardt SG
    Clin Cancer Res; 1999 Jul; 5(7):1629-37. PubMed ID: 10430061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tirapazamine-cisplatin: the synergy.
    Gatzemeier U; Rodriguez G; Treat J; Miller V; von Roemeling R; Viallet J; Rey A
    Br J Cancer; 1998 Jun; 77 Suppl 4(Suppl 4):15-7. PubMed ID: 9647615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II evaluation of tirapazamine plus cisplatin in the treatment of recurrent platinum-sensitive ovarian or primary peritoneal cancer: a Gynecologic Oncology Group study.
    Covens A; Blessing J; Bender D; Mannel R; Morgan M;
    Gynecol Oncol; 2006 Mar; 100(3):586-90. PubMed ID: 16249022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of escalated dose of tirapazamine combined with cisplatin in advanced malignant melanoma.
    Bedikian AY; Legha SS; Eton O; Buzaid AC; Papadopoulos N; Plager C; McIntyre S; Viallet J
    Anticancer Drugs; 1999 Sep; 10(8):735-9. PubMed ID: 10573206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I and pharmacokinetic trial of the novel taxane BMS-184476 administered as a 1-hour intravenous infusion in combination with cisplatin every 21 days.
    Sun W; Stevenson JP; Gallagher ML; Vaughn D; Hahn SM; Haller DG; Cohen M; Kopit J; Gallant G; O'Dwyer PJ
    Clin Cancer Res; 2003 Nov; 9(14):5221-7. PubMed ID: 14614002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I trial of intravenous cisplatin-topotecan chemotherapy for three consecutive days in patients with advanced solid tumors: parallel topotecan escalation in two fixed platinum dosing schemes.
    Pentheroudakis G; Briasoulis E; Karavassilis V; Mauri D; Tzamakou E; Rammou D; Pavlidis N
    Chemotherapy; 2005 May; 51(2-3):154-61. PubMed ID: 15886476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I study of tirapazamine plus cisplatin/etoposide and concurrent thoracic radiotherapy in limited-stage small cell lung cancer (S0004): a Southwest Oncology Group study.
    Le QT; McCoy J; Williamson S; Ryu J; Gaspar LE; Edelman MJ; Dakhil SR; Sides SD; Crowley JJ; Gandara DR;
    Clin Cancer Res; 2004 Aug; 10(16):5418-24. PubMed ID: 15328179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of tirapazamine combined with cisplatin in chemotherapy of advanced malignant melanoma.
    Bedikian AY; Legha SS; Eton O; Buzaid AC; Papadopoulos N; Coates S; Simmons T; Neefe J; von Roemeling R
    Ann Oncol; 1997 Apr; 8(4):363-7. PubMed ID: 9209666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscle cramping in phase I clinical trials of tirapazamine (SR 4233) with and without radiation.
    Doherty N; Hancock SL; Kaye S; Coleman CN; Shulman L; Marquez C; Mariscal C; Rampling R; Senan S; Roemeling RV
    Int J Radiat Oncol Biol Phys; 1994 May; 29(2):379-82. PubMed ID: 8195037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II study of tirapazamine plus cisplatin in patients with advanced or recurrent cervical cancer.
    Maluf FC; Leiser AL; Aghajanian C; Sabbatini P; Pezzulli S; Chi DS; Wolf JK; Levenback C; Loh E; Spriggs DR
    Int J Gynecol Cancer; 2006; 16(3):1165-71. PubMed ID: 16803501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.